FRESENIUS KABI ONCOLOGY LIMITED

Manufacturer

Fresenius Kabi Oncology Limited is a manufacturing company based in India, operating as a subsidiary of the global healthcare group Fresenius Kabi AG. The company specializes in the development, manufacturing, and marketing of high-quality generic oncology products, which are medicines used in the treatment of cancer.

It maintains state-of-the-art production facilities in India, adhering to international regulatory standards to produce sterile injectable drugs, biosimilars, and other critical care products primarily for oncology. Its operations encompass research and development, production, and distribution, serving both the Indian market and global exports. Fresenius Kabi Oncology Limited plays a significant role in providing essential and affordable cancer therapies worldwide, contributing to improved patient outcomes.

Products manufactured or sold by Fresenius Kabi Oncology Limited in India:

Pemetrexed

Docetaxel

Paclitaxel

Gemcitabine

Carboplatin

Cisplatin

Oxaliplatin

Irinotecan

Cyclophosphamide

5-Fluorouracil

Methotrexate

Doxorubicin

Epirubicin

Topotecan

Vinorelbine

Bortezomib

Trastuzumab

Rituximab

Filgrastim

Pegfilgrastim

Epoetin alfa

Iron Sucrose